BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26825841)

  • 21. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
    Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
    Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
    Bae HS; Kim YJ; Lim MC; Seo SS; Park SY; Kang S; Kim SH; Kim JY
    Int J Gynecol Cancer; 2016 May; 26(4):737-42. PubMed ID: 26937749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Clinical Manifestations and Survival Outcomes between Neuroendocrine Tumor and Squamous Cell Carcinoma of the Uterine Cervix: Results from a Tertiary Center in Southern Thailand.
    Sodsanrat K; Saeaib N; Liabsuetrakul T
    J Med Assoc Thai; 2015 Aug; 98(8):725-33. PubMed ID: 26437528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
    Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
    Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
    Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
    Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
    Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
    Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
    Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
    Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
    Nugent EK; Case AS; Hoff JT; Zighelboim I; DeWitt LL; Trinkhaus K; Mutch DG; Thaker PH; Massad LS; Rader JS
    Gynecol Oncol; 2010 Mar; 116(3):438-41. PubMed ID: 19896180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C; Reyhan M; Parlak C; Guler OC; Oymak E
    Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
    Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-Dimensional Power Doppler Ultrasound for Predicting Response and Local Recurrence After Concomitant Chemoradiation Therapy for Locally Advanced Carcinoma of the Cervix.
    Alcazar JL; Arribas S; Martinez-Monge R; Jurado M
    Int J Gynecol Cancer; 2016 Mar; 26(3):534-8. PubMed ID: 26745701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
    Behtash N; Karimi Zarchi M; Deldar M
    Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.
    Landrum LM; Skaggs V; Gould N; Walker JL; McMeekin DS
    Gynecol Oncol; 2008 Mar; 108(3):584-90. PubMed ID: 18155755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A retrospective review of patients with stage IB2 cervical cancer treated with radical radiation versus radical surgery as a primary modality.
    Alleyne-Mike K; van Wijk L; Hunter A
    Int J Gynecol Cancer; 2013 Sep; 23(7):1287-94. PubMed ID: 23863456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
    Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
    Mori T; Hosokawa K; Sawada M; Kuroboshi H; Tatsumi H; Koshiba H; Okubo T; Kitawaki J
    Int J Gynecol Cancer; 2010 May; 20(4):611-6. PubMed ID: 20686381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.